Sedation options for suture removal after cleft surgery in young children
Official title: Comparison of Intramuscular Ketamine and Intranasal Nalbuphine and Dexmedetomidine for Analgosedation in Children Undergoing Suture Removal After Surgery for Congenital Clefts of the Palate, Alveolar Ridge, and Lip
Run by University Medical Centre Ljubljana · NCT07340008 · Data updated 2026-11-12
This trial tests whether intramuscular ketamine, intranasal nalbuphine, or intranasal dexmedetomidine provide faster, safer, and more comfortable sedation for children aged 6 months to 3 years during suture removal after cleft surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 6 Months to 3 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | University Medical Centre Ljubljana Academic / other |
| Locations | 1 site (Ljubljana) |
| Status | Recruiting |
| Started | September 1, 2025 |
| Main results expected | January 2028 |
| Study ends | January 2029 |
| Registry record updated | January 14, 2026 |
| Trial ID | NCT07340008 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 6 months to 3 years with ASA physical status I–II scheduled for suture removal after congenital cleft lip, palate, or alveolar ridge surgery whose parents or guardians provide informed consent and speak Slovene are ideal candidates.
✕Probably not a fit
Children with ASA status greater than II, significant neurological, psychiatric, respiratory or developmental disorders, recent upper respiratory infection, known allergy to the study drugs, or whose families do not consent or speak Slovene are not eligible and unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, randomized trial enrolling 60 children aged 6 months to 3 years who need suture removal after cleft lip, palate, or alveolar ridge surgery. Participants are randomly assigned to one of three sedative-analgesic regimens: intramuscular ketamine, intranasal nalbuphine, or intranasal dexmedetomidine. Primary outcomes include time to reach adequate sedation (Modified Ramsay Sedation Scale 2–3), surgeon-rated ease of the procedure, and time to discharge readiness (Modified Aldrete Score ≥9); secondary outcomes include baseline behavior, response to drug administration, depth of sedation, separation response, parental satisfaction, and monitoring of complications and vital signs. All medications are approved and commonly used in pediatric anesthesia, and the trial is conducted at the Department of Maxillofacial and Oral Surgery, University Medical Centre Ljubljana.
Why it matters
Potential benefit: If successful, the trial could identify the quickest and safest sedation approach that improves child comfort, shortens procedure time, and speeds safe discharge after suture removal.
How similar studies have gone: All three drugs are commonly used in pediatric sedation and prior studies have shown effective sedation with ketamine, dexmedetomidine, or nalbuphine in various pediatric procedures, though direct head-to-head comparisons for suture removal after cleft surgery are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: * Age 6 months to 3 years * Scheduled for suture removal after surgery for congenital cleft of the palate, alveolar ridge, or lip * American Society of Anesthesiologists (ASA) physical status I or II * Written informed consent obtained from parents or legal guardians * Slovene-speaking family to ensure understanding and compliance * No contraindications to the use of study medications Exclusion criteria: * Known allergy or hypersensitivity to ketamine, nalbuphine, or dexmedetomidine * ASA physical status greater than II * Significant neurological, psychiatric, or respiratory disorder * Active or recent upper respiratory tract infection * Refusal of parental or guardian consent * Developmental disorder affecting communication or cooperation
Where it's running
-
Department of Maxillofacial and Oral Surgery, University Medical Centre Ljubljana
Ljubljana, Slovenia Recruiting
Study contacts
- Study coordinator: Liljana Markova, MD, PhD
- Email: liljana.markova@kclj.si
- Phone: 00 386 40 802 662
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Perceptions of High and Low Intensity Speech Intervention in Children with a Cleft Palate
This study looks at how providers and children with cleft palate and their parents feel about high- versus low-intensity speech therapy to see which is more acceptable and helpful.
-
Using clear aligners to expand the upper dental arch in children with cleft lip and palate
This study is testing if clear aligners can help expand the upper jaw in children aged 6-8 with cleft lip and palate.
-
Comparing speech interventions for children with cleft palate
This study is trying to find out if high or low intensity speech therapy works better for children with cleft palate by talking to the kids, their caregivers, and speech therapists about their experiences.
-
Optical genome mapping to find genetic causes of congenital orofacial clefts
This will test whether optical genome mapping on a blood sample can find structural genetic changes in people with syndromic, complex, or familial orofacial clefts who do not yet have a genetic diagnosis.
-
Comparing single and multiple surgeries for nasal and alveolar repairs in cleft lip and palate patients
This study is testing whether doing all the necessary nose and gum repairs in one surgery is better than spreading them out over multiple surgeries for kids with cleft lip and palate.
-
Using a bioengineered tissue to treat cleft palate in children
This study is testing a new bioengineered tissue to see if it can help children with cleft palate heal better than the usual surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.